| Original language | English (Ireland) |
|---|---|
| Media of output | Abstract |
| Volume | 124 |
| Publication status | Published - 1 Dec 2014 |
Pomalidomide Plus Low-Dose Dexamethasone (POM plus LoDEX) for Relapsed and Refractory Multiple Myeloma (RRMM): Results from a Pharmacoeconomic Evaluation
- Michael O'Dwyer
Research output: Other contribution (Published) › Other contribution